296 related articles for article (PubMed ID: 20410056)
41. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.
Currow DC; Quinn S; Agar M; Fazekas B; Hardy J; McCaffrey N; Eckermann S; Abernethy AP; Clark K
J Pain Symptom Manage; 2015 May; 49(5):814-21. PubMed ID: 25462210
[TBL] [Abstract][Full Text] [Related]
42. [Appetite loss, nausea, vomiting].
Sakamaki S
Nihon Rinsho; 2007 Jan; 65(1):69-75. PubMed ID: 17233418
[TBL] [Abstract][Full Text] [Related]
43. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
44. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
[TBL] [Abstract][Full Text] [Related]
45. A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting.
Ho CL; Su WC; Hsieh RK; Lin ZZ; Chao TY
Jpn J Clin Oncol; 2010 Apr; 40(4):294-301. PubMed ID: 20026457
[TBL] [Abstract][Full Text] [Related]
46. A dual-design expandable colorectal stent for malignant colorectal obstruction: results of a multicenter study.
Song HY; Kim JH; Shin JH; Kim HC; Yu CS; Kim JC; Kang SG; Yoon CJ; Lee JY; Koo JH; Lee KH; Kim JK; Kim DH; Shin TB; Jung GS; Han YM
Endoscopy; 2007 May; 39(5):448-54. PubMed ID: 17516352
[TBL] [Abstract][Full Text] [Related]
47. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
[TBL] [Abstract][Full Text] [Related]
50. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.
Ripamonti C; Mercadante S; Groff L; Zecca E; De Conno F; Casuccio A
J Pain Symptom Manage; 2000 Jan; 19(1):23-34. PubMed ID: 10687323
[TBL] [Abstract][Full Text] [Related]
51. Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and beta-endorphin levels.
Befon S; Mystakidou K; Lyra M; Tubanakis N; Vlahos L
Anticancer Res; 2000; 20(5C):4039-46. PubMed ID: 11268498
[TBL] [Abstract][Full Text] [Related]
52. Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center.
Walter M; Hansen E; Hamid S; Carozza D; Mann G; Roche C; George A; Attwood K; Case A
J Pain Symptom Manage; 2024 Jan; 67(1):20-26. PubMed ID: 37769820
[TBL] [Abstract][Full Text] [Related]
53. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.
Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V
J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515
[TBL] [Abstract][Full Text] [Related]
54. Gastric electrical stimulation in medically refractory nausea and vomiting.
Gourcerol G; Leblanc I; Leroi AM; Denis P; Ducrotte P
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):29-35. PubMed ID: 17206074
[TBL] [Abstract][Full Text] [Related]
55. Effect of somatostatin analogue octreotide on pain relief after major abdominal surgery.
Dahaba AA; Mueller G; Mattiassich G; Rumpold-Seitlinger G; Bornemann H; Rehak PH; Linck G; Mischinger HJ; Metzler H
Eur J Pain; 2009 Sep; 13(8):861-4. PubMed ID: 19084439
[TBL] [Abstract][Full Text] [Related]
56. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction.
Mercadante S; Spoldi E; Caraceni A; Maddaloni S; Simonetti MT
Palliat Med; 1993; 7(4):295-9. PubMed ID: 7505187
[TBL] [Abstract][Full Text] [Related]
57. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
Kaneishi K; Kawabata M; Morita T
J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
[TBL] [Abstract][Full Text] [Related]
58. Can malignant bowel obstruction in advanced cancer patients be treated at home?
Porzio G; Aielli F; Verna L; Galletti B; Shoja E Razavi G; Ficorella C
Support Care Cancer; 2011 Mar; 19(3):431-3. PubMed ID: 20872024
[TBL] [Abstract][Full Text] [Related]
59. Antisecretory agents in gastrointestinal obstruction.
Muir JC; von Gunten CF
Clin Geriatr Med; 2000 May; 16(2):327-34. PubMed ID: 10783431
[TBL] [Abstract][Full Text] [Related]
60. [Conservative treatment for inoperable malign intestinal obstruction].
Saarto T; Osterlund P; Lepistö A
Duodecim; 2013; 129(4):410-7. PubMed ID: 23484358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
